Tarsus Pharmaceuticals, Inc. TARS Capital investments accrued but not yet paid
Capital investments accrued but not yet paid at other companies
Other financials
Where this comes from
Reported directly by Tarsus Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept us-gaap:CapitalExpendituresIncurredButNotYetPaid.
The official record: Tarsus Pharmaceuticals, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Tarsus Pharmaceuticals, Inc.'s capital investments accrued but not yet paid.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Tarsus Pharmaceuticals, Inc.'s capital investments accrued but not yet paid?
- Tarsus Pharmaceuticals, Inc. (TARS) reported capital investments accrued but not yet paid of $911K in Q1 2026.
- How has Tarsus Pharmaceuticals, Inc.'s capital investments accrued but not yet paid changed year-over-year?
- Tarsus Pharmaceuticals, Inc.'s capital investments accrued but not yet paid increased by 2235.9% year-over-year, from $39K to $911K.
- What is the long-term trend for Tarsus Pharmaceuticals, Inc.'s capital investments accrued but not yet paid?
- Over 3 years (2021 to 2025), Tarsus Pharmaceuticals, Inc.'s capital investments accrued but not yet paid has grown at a 814.8% compound annual growth rate (CAGR), from $2K to $1.53M.